|
Name |
cis,trans-Muconic acid
|
Molecular Formula | C6H6O4 | |
IUPAC Name* |
(2Z,4E)-hexa-2,4-dienedioic acid
|
|
SMILES |
C(=C/C(=O)O)\C=C/C(=O)O
|
|
InChI |
InChI=1S/C6H6O4/c7-5(8)3-1-2-4-6(9)10/h1-4H,(H,7,8)(H,9,10)/b3-1-,4-2+
|
|
InChIKey |
TXXHDPDFNKHHGW-HSFFGMMNSA-N
|
|
Synonyms |
cis,trans-muconic acid; (2Z,4E)-hexa-2,4-dienedioic acid; 1119-73-9; Muconic acid, (E,Z)-; (E,Z)-Muconic acid; Muconic acid (2E,4Z)-form [MI]; 2,4-Hexadienedioic acid, (2E,4Z)-; 10Z8SOV21M; (2E,4Z)-2,4-hexadienedioic acid; UNII-10Z8SOV21M; cis-muconic acid; cis,trans muconic acid; starbld0020403; cis,trans-Hexadienedioate; cis,trans-MuconsA currencyure; SCHEMBL820982; CHEBI:27671; DTXSID101304080; ZINC13509058; 2,4-HEXADIENEDIOIC ACID, CIS,TRANS; C03647; Q27103253
|
|
CAS | 1119-73-9 | |
PubChem CID | 5280614 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 142.11 | ALogp: | 0.2 |
HBD: | 2 | HBA: | 4 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 74.6 | Aromatic Rings: | 0 |
Heavy Atoms: | 10 | QED Weighted: | 0.448 |
Caco-2 Permeability: | -5.696 | MDCK Permeability: | 0.00002380 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.04 |
Human Intestinal Absorption (HIA): | 0.305 | 20% Bioavailability (F20%): | 0.082 |
30% Bioavailability (F30%): | 0.999 |
Blood-Brain-Barrier Penetration (BBB): | 0.079 | Plasma Protein Binding (PPB): | 49.07% |
Volume Distribution (VD): | 0.359 | Fu: | 36.95% |
CYP1A2-inhibitor: | 0.016 | CYP1A2-substrate: | 0.04 |
CYP2C19-inhibitor: | 0.058 | CYP2C19-substrate: | 0.037 |
CYP2C9-inhibitor: | 0.258 | CYP2C9-substrate: | 0.1 |
CYP2D6-inhibitor: | 0.05 | CYP2D6-substrate: | 0.124 |
CYP3A4-inhibitor: | 0.031 | CYP3A4-substrate: | 0.013 |
Clearance (CL): | 2.25 | Half-life (T1/2): | 0.875 |
hERG Blockers: | 0.001 | Human Hepatotoxicity (H-HT): | 0.812 |
Drug-inuced Liver Injury (DILI): | 0.803 | AMES Toxicity: | 0.014 |
Rat Oral Acute Toxicity: | 0.362 | Maximum Recommended Daily Dose: | 0.011 |
Skin Sensitization: | 0.843 | Carcinogencity: | 0.057 |
Eye Corrosion: | 0.979 | Eye Irritation: | 0.992 |
Respiratory Toxicity: | 0.899 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001095 | 0.643 | D06VNK | 0.278 | ||||
ENC005534 | 0.370 | D0G4JI | 0.258 | ||||
ENC003852 | 0.357 | D01GYK | 0.250 | ||||
ENC004112 | 0.356 | D00ENY | 0.244 | ||||
ENC004134 | 0.311 | D0A7MY | 0.238 | ||||
ENC002791 | 0.293 | D0RN2W | 0.233 | ||||
ENC003005 | 0.286 | D0X5SI | 0.227 | ||||
ENC000062 | 0.278 | D0V9EN | 0.220 | ||||
ENC001586 | 0.270 | D05ZGQ | 0.220 | ||||
ENC003253 | 0.265 | D0FG6M | 0.219 |